 Immunogenicity will be evaluated in all subjects prior to vaccination on Day 0 Visit 1 and at Day 28 after the final vaccination using the hemagglutination inhibition technique. For each influenza vaccine strain, pre- and post-vaccination geometric mean titers will be calculated. 